BioAsia 2026 Positions Hyderabad at the Heart of Global Healthcare Innovation

• BioAsia 2026 highlights AI driven biology revolution.
• Hyderabad hosts global life sciences leaders.
• BioAsia strengthens Hyderabad healthcare hub status.

Hyderabad is set to take global centre stage as BioAsia returns with its 23rd edition, bringing together the world’s leading minds in life sciences, biotechnology and healthcare for a high impact international conference.

Recognised as one of the most prestigious platforms in the life sciences sector, BioAsia 2026 will be held under the theme TechBio Unleashed AI Automation Biology Revolution. The two day summit will see participation from nearly three thousand delegates representing fifty countries, signalling Hyderabad’s growing global influence in healthcare innovation.

The event will be inaugurated on February 17 by Revanth Reddy along with Industries Minister D Sridhar Babu. Their presence underscores the Telangana government’s focus on positioning the state as a preferred destination for life sciences investment.

This year’s conference will place strong emphasis on how artificial intelligence and automation are transforming biology, drug discovery and medical research. Global pharmaceutical and biotech leaders from companies such as Amgen, Sanofi and Eli Lilly are expected to share insights on emerging scientific breakthroughs.

Renowned experts including cancer gene therapy specialist Professor Bruce L Levine and Amgen Chief Scientific Officer Doctor Howard Y Chang will deliver keynote addresses. The conference will also feature prominent Indian voices such as Principal Scientific Adviser to the Government of India Professor Ajay Kumar Sood and former ISRO chairman S Somanath, adding depth to the discussions.

A major highlight of BioAsia 2026 will be the exclusive CEO Conclave, where Indian pharma giants like Dr Reddys, Biocon and Cipla will engage with global players including Novartis and AstraZeneca. Discussions will focus on advanced areas such as cell and gene therapy, mRNA technology and the future of precision medicine.

Through policy dialogue innovation showcases and global collaboration, BioAsia 2026 aims to strengthen the global bio economy while reinforcing Hyderabad’s reputation as a leading healthcare and life sciences hub. The summit is expected to open new pathways for investment innovation and technology driven healthcare solutions with global impact.